0001209191-20-028067.txt : 20200508
0001209191-20-028067.hdr.sgml : 20200508
20200508182439
ACCESSION NUMBER: 0001209191-20-028067
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200209
FILED AS OF DATE: 20200508
DATE AS OF CHANGE: 20200508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PATTERSON LEONE D
CENTRAL INDEX KEY: 0001233539
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36579
FILM NUMBER: 20862142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adverum Biotechnologies, Inc.
CENTRAL INDEX KEY: 0001501756
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 205258327
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-272-6269
MAIL ADDRESS:
STREET 1: 800 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: Avalanche Biotechnologies, Inc.
DATE OF NAME CHANGE: 20100921
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2020-02-09
2020-02-10
0
0001501756
Adverum Biotechnologies, Inc.
ADVM
0001233539
PATTERSON LEONE D
C/O ADVERUM BIOTECHNOLOGIES, INC.
800 SAGINAW DRIVE
REDWOOD CITY
CA
94063
1
1
0
0
CEO, President and Director
Common Stock
2020-02-09
4
F
0
10985
10.24
D
139235
D
Reflects shares withheld by the Issuer upon vesting of restricted stock units to satisfy withholding tax obligations.
This Form 4 Amendment is being filed solely to correct the amount of shares surrendered to satisfy a tax withholding obligation in Table I. The amount previously reflected was 11,215 shares and should have been reflected as 10,985 shares. As a result, the number of shares beneficially owned in Box 5 of Table I has been adjusted accordingly.
Leone Patterson by /s/ Thomas Leung, Attorney-in-Fact.
2020-05-08